Skip to contentC
CV Sciences, Inc.
C
CVSICV Sciences, Inc. Q1 2015 · 10-Q
Revenue$2.71M$2.71M+3.1% vs Q1 2014 Net Income-$2.65M-$2.65MN/M vs Q1 2014 EPS Diluted-$0.08-$0.08— vs Q1 2014 Gross Profit$1,577,946−2.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CV Sciences, Inc. · CIK 1510964 · Engraved from SEC EDGAR
Operating Cash Flow-$2,582,851N/M Free Cash Flowderived-$2,657,549N/M Margins · derivedGross margin58.1%−3.1 pt vs Q1 2014
Operating margin-99.0%−119.3 pt vs Q1 2014
Net margin-97.6%−93.1 pt vs Q1 2014
ended Mar 31, 2015 · filed May 15, 2015 · 45 d after period end